Clinical Trial Update: Lithium for Prevention of Cognitive Declining in Mood Illnesses [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on lithium for prevention of cognitive decline in mood disorders, with current status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Cognitive Impairment
• Dementia
• Major Depressive Disorder

Drugs mentioned

• Lithium (Lithium carbonate)

Snippet

Sponsor: University of Chile | Conditions: Dementia, Bipolar Disorder (BD) | Phase 4 | Status: NOT_YET_RECRUITING